Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRS | BHRB |
|---|---|---|
| Price | $38.93 | $69.28 |
| Change today | ▼ 0.49% | ▼ 0.83% |
| Market cap | $1.40B | $1.40B |
| Return, 3 months | -4.4% | +0.1% |
| Return, year to date | +10.1% | +13.9% |
| Return, 1 year | +5.3% | +16.4% |
| P/E (TTM) | 1.6 | 11.3 |
| P/B | 1.0 | 1.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.41% | 3.18% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 49 | 43 |
| 30-day volatility | 17.7% | 13.9% |
| Max drawdown, 1 year | -22.1% | -13.1% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
